BMS-193884 is an orally bioavailable endothelin antagonist for the potential treatment of congestive heart failure (CHF) and pulmonary hypertension. References: Dhaun N, Strachan FE, Newby DE, Johnston NR, Ford NF, Hammett JL, Palmisano M, Webb DJ. Vasodilator effects of the endothelin ET receptor selective antagonist BMS-193884 in healthy men. Br J Clin Pharmacol. 2005 Dec;60(6):611-22. PubMed PMID: 16305585; PubMed Central PMCID: PMC1884878.

纯度：≥98%

CAS：176960-47-7